好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Corticotherapy Versus Adrenocorticotrophic Hormone for the Treatment of West Syndrome: a Systematic Review and Meta-analysis
Epilepsy/Clinical Neurophysiology (EEG)
P12 - Poster Session 12 (11:45 AM-12:45 PM)
9-006
The objective was to present an updated review comparing the therapeutic and adverse effects of adrenocorticotropic hormone (ACTH) therapy versus corticosteroids in children with Infantile Spasms.
Although it is known that the most commonly used therapies for West Syndrome are intramuscular ACTH and oral prednisolone, there is still controversy in the literature regarding the equivalence of their effects. The importance of elucidating the superiority of one drug over the other lies in the difference in their costs.
PubMed, EMBASE, and Cochrane Central were used as search tools. The outcomes of interest selected were spasm cessation on day 14 of therapy, cessation of hypsarrhythmia and adverse effects such as weight gain, infection, irritability, and hypertension. Statistical analysis was performed using RevMan 5.1.7.
1,998 articles were screened and 7 RCTs and 429 patients were included. Compared with Corticoids, ACTH was associated with a bigger reduction in weight gain (RR 1.41; 95% CI 1.01 - 1.97; p=0.04; I²=0%). There was no significant difference in cessation of spasms on day 14 (OR 0.91; 95% CI 0.47 - 1.47; p=0.79), hypsarrhythmia (OR 0.97; 95% CI 0,22 - 4.34), irritability (RR 0.78; 95% CI 0.30 - 1.99), hypertension (RR 0.64; 95% CI 0.35 - 1.15; p=0.14), and infection (RR 0.69; 95% CI 0.19 - 2.50; p=0.57). 

This study provides robust evidence regarding the safety and efficacy of ACTH or corticoids in children with epileptic spasms. However, the significant heterogeneity between studies restricts the analysis, emphasizing the necessity for additional research to assess the best option to treat infantile spasms.


Authors/Disclosures
Aishwarya Koppanatham, MBBS
PRESENTER
Ms. Koppanatham has nothing to disclose.
Elizabeth H. de Farias II, medical academic Mrs. de Farias has nothing to disclose.
Altair P. de Melo Neto, Student Mr. de Melo Neto has nothing to disclose.
Julia Cappi Aguiar Moraes Souza, MS Ms. Cappi Aguiar Moraes Souza has nothing to disclose.
Raphael Besborodco, MD (NYU) Dr. Besborodco has nothing to disclose.
Gabrielle d. Rocha, PhD Prof. Rocha has nothing to disclose.